Vannozzi MO - Search Results

1

High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule.

Ballestrero A, Ferrando F, Garuti A, Basta P, Gonella R, Esposito M, Vannozzi MO, Sorice G, Friedman D, Puglisi M, Brema F, Mela GS, Sessarego M, Patrone F. Ballestrero A, et al. Among authors: vannozzi mo. Br J Cancer. 1997;76(6):797-804. doi: 10.1038/bjc.1997.465. Br J Cancer. 1997. PMID: 9310249 Free PMC article. Clinical Trial.

2

Protective effect on cisplatin hematotoxicity by procaine hydrochloride.

Esposito M, Lerza R, Mencoboni M, Vannozzi M, Flego G, Bogliolo G, Merlo F, Pannacciulli I. Esposito M, et al. Cancer Lett. 1992 May 30;64(1):55-60. doi: 10.1016/0304-3835(92)90022-n. Cancer Lett. 1992. PMID: 1596878

3

High doses of intrapleural cisplatin in a case of malignant pleural mesothelioma. Clinical observations and pharmacokinetic analyses.

Lerza R, Esposito M, Vannozzi M, Bottino GB, Bogliolo G, Pannacciulli I. Lerza R, et al. Cancer. 1994 Jan 1;73(1):79-84. doi: 10.1002/1097-0142(19940101)73:1<79::aid-cncr2820730115>3.0.co;2-0. Cancer. 1994. PMID: 8275441

4

Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.

Miglietta L, Canobbio L, Granetto C, Vannozzi MO, Esposito M, Boccardo F. Miglietta L, et al. Among authors: vannozzi mo. J Cancer Res Clin Oncol. 1997;123(7):407-10. doi: 10.1007/BF01240125. J Cancer Res Clin Oncol. 1997. PMID: 9260594 Clinical Trial.

5

Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study.

Civalleri D, Vannozzi MO, De Cian F, Lunardi G, Steinweg M, Pastrone I, Viale M, Esposito M. Civalleri D, et al. Among authors: vannozzi mo. Eur J Surg Oncol. 2002 Mar;28(2):172-9. doi: 10.1053/ejso.2001.1218. Eur J Surg Oncol. 2002. PMID: 11884053

6

Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases.

Civalleri D, Esposito M, Fulco RA, Vannozzi M, Balletto N, De Cian F, Percivale PL, Merlo F. Civalleri D, et al. Cancer. 1991 Sep 1;68(5):988-94. doi: 10.1002/1097-0142(19910901)68:5<988::aid-cncr2820680513>3.0.co;2-8. Cancer. 1991. PMID: 1913493 Clinical Trial.

7

In situ lung perfusion with cisplatin. An experimental study.

Ratto GB, Esposito M, Leprini A, Civalleri D, De Cian F, Vannozzi MO, Romano P, Canepa M, Zaccheo D. Ratto GB, et al. Among authors: vannozzi mo. Cancer. 1993 May 15;71(10):2962-70. doi: 10.1002/1097-0142(19930515)71:10<2962::aid-cncr2820711013>3.0.co;2-f. Cancer. 1993. PMID: 8490824

8

Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.

Viale M, Vannozzi MO, Merlo F, Cafaggi S, Parodi B, Esposito M. Viale M, et al. Among authors: vannozzi mo. Eur J Cancer. 1996 Dec;32A(13):2327-33. doi: 10.1016/s0959-8049(96)00354-1. Eur J Cancer. 1996. PMID: 9038617

9

Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells.

Repetto L, Vannozzi MO, Balleari E, Venturino A, Granetto C, Bason C, Simoni C, Prencipe E, Queirolo P, Esposito M, Ghio R, Rosso R. Repetto L, et al. Among authors: vannozzi mo. Anticancer Res. 1999 Jan-Feb;19(1B):879-84. Anticancer Res. 1999. PMID: 10216510 Clinical Trial.

10

Regional pharmacokinetic selectivity of intrapleural cisplatin.

Bogliolo GV, Lerza R, Bottino GB, Mencoboni MP, Pannacciulli IM, Vannozzi M, Fulco RA, Merlo F, Esposito M. Bogliolo GV, et al. Eur J Cancer. 1991;27(7):839-42. doi: 10.1016/0277-5379(91)90129-2. Eur J Cancer. 1991. PMID: 1834113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters